Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma

Annals of Oncology

Volumn 19, Issue 12, 2008, Pages 2043-2047

  Luthy, S K ^a   Ng, A K ^a,c   Silver, B ^a   Degnan, K O ^a   Fisher, D C ^b   Freedman, A S ^b   Mauch, P M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Institute for Gynecological Oncology   (Germany)

Author keywords

Eadiation therapy; Non Hodgkin's lymphoma; Palliation

Indexed keywords

RITUXIMAB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LOW ENERGY RADIATION; MALE; NONHODGKIN LYMPHOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; SYSTEMIC THERAPY; TREATMENT RESPONSE;

EID: 56749156615     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn529     Document Type: Article

References (14)

1. Hoppe RT. The non-Hodgkin's lymphomas: Pathology, staging, treatment. Curr Probl Cancer 1987; 11(6): 363-447.
2. Guadagnolo BA, Li S, Neuberg D et al. Long-term outcome and mortality trends in early-stage, grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006: 64(3): 928-934.
3. Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14(4): 1282-1290.
4. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA et al. Clinical stage 1 non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994; 69(6): 1088-1093.
5. Wilder RB, Jones D, Tucker SL et al. Long-term results with radiotherapy for stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys 2001: 51(5): 1219-1227.
6. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994; 83(4): 881-884.
7. Ganem G, Lambin P, Socié G et al. Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol 1994; 12(1): 1-8.
8. Girinsky T, Guillot-Vals D, Koscielny S et al. A highland sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: Analysis of predictive parameters of response to treatment. Int J Radiat Orcol Biol Phys 2001; 51(1): 148-155.
9. Haas RL, Poortmans P, de Jong D et al. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol 2003; 21(13): 2474-2480.
10. Jóhannsson J, Specht L, Mejer J et al. Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Int J Radiat Oncol Biol Phys 2002; 54(5): 1466-1470.
11. Sawyer EJ, Timothy AR. Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma. Radiother Oncol 1997; 42(1): 49-51.
12. Haas RL, Poortmans P, de Jong D et al. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patents. Eur J Cancer 2005; 41(12): 1724-1730.
13. Montoto S, Davies AJ, Matthews J et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007; 25(17): 2426-2433.
14. Tsang RW, Gospodarowicz MK. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. Hematol Oncol 2005; 23(1): 10-17.